Timur Ivannikov
Stock Analyst at Raymond James
(0.58)
# 3,831
Out of 4,832 analysts
6
Total ratings
50%
Success rate
-26.14%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Timur Ivannikov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATXS Astria Therapeutics | Reiterates: Overweight | $47 | $4.07 | +1,054.79% | 1 | May 14, 2025 | |
| GOSS Gossamer Bio | Downgrades: Market Perform | $5 | $1.06 | +373.93% | 2 | Mar 7, 2023 | |
| ANAB AnaptysBio | Downgrades: Market Perform | n/a | $19.58 | - | 1 | Jan 6, 2023 | |
| RCKT Rocket Pharmaceuticals | Initiates: Outperform | $22 | $6.43 | +242.15% | 1 | Jul 8, 2022 | |
| APLS Apellis Pharmaceuticals | Maintains: Strong Buy | $112 → $114 | $16.97 | +571.77% | 1 | Mar 1, 2022 |
Astria Therapeutics
May 14, 2025
Reiterates: Overweight
Price Target: $47
Current: $4.07
Upside: +1,054.79%
Gossamer Bio
Mar 7, 2023
Downgrades: Market Perform
Price Target: $5
Current: $1.06
Upside: +373.93%
AnaptysBio
Jan 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $19.58
Upside: -
Rocket Pharmaceuticals
Jul 8, 2022
Initiates: Outperform
Price Target: $22
Current: $6.43
Upside: +242.15%
Apellis Pharmaceuticals
Mar 1, 2022
Maintains: Strong Buy
Price Target: $112 → $114
Current: $16.97
Upside: +571.77%